Treatment with (R)-albuterol has no advantage over racemic albuterol.
Barnes
Peter J
PJ
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D000420:Albuterol / Q000008:administration & dosage / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D001985:Bronchial Provocation Tests; D017281:Cost of Illness; D004305:Dose-Response Relationship, Drug; D006801:Humans
D000318:Adrenergic beta-Agonists; D000420:Albuterol